Focus area
Genomics Investment Firms
The RaiseHunt database lists 743 Genomics investment firms: 738 of them list a portfolio, 6,287 known investments between them and 2,693 people at those firms have a profile here. Most list Seed and Series A among the rounds they take part in; the largest concentrations are in San Francisco, New York and Boston.
- 743
- Investment firms
- 738
- With a known portfolio
- 6,287
- Known investments
- 2,693
- People with a profile
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
743 Genomics investment firms
Showing 1-20
Filters
| Firm | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
AV Apex Ventures | Austria | Venture capital | AIClimate | View fund | |
PF Pioneer Fund | San Francisco, United States | AcceleratorSyndicate / Angel group | AICommerce | View fund | |
DM Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | View fund | |
M Morningside | Boston, United States | Private equityVenture capital | AIFinTech | View fund | |
AR Alexandria Real Estate Equities | San Francisco, United States | Corporate VC | HealthcareReal Estate | View fund | |
NC Nucleus Capital | Berlin, Germany | Venture capital | AIClimate | View fund | |
S Sanofi | Cambridge, United States | Corporate VC | AIHealthcare | View fund | |
A Amgen | Raleigh, United States | Corporate VC | AIHardware | View fund | |
RV Radius Ventures | Indianapolis, United States | Corporate VCVenture capital | AICommerce | View fund | |
H HealthCap | Stockholm, Sweden | Venture capital | FinTechHealthcare | View fund | |
CC CD Capital | Shanghai, China | Private equityVenture capital | HardwareHealthcare | View fund | |
WC Wormhole Capital | New York, United States | Venture capital | AICommerce | View fund | |
AI ARK Investment Management | St. Petersburg, United States | Venture debt | AIConsumer | View fund | |
CI California Institute for Regenerative Medicine | San Francisco, United States | Government-backed | EducationHealthcare | View fund | |
EF Entrepreneurs First | London, United Kingdom | AcceleratorVenture capital | AIHardware | View fund | |
L Labcorp | Durham, United States | Corporate VC | AIHealthcare | View fund | |
MA Mirae Asset Venture Investment | Seoul, South Korea | Corporate VCPrivate equity | AIFinTech | View fund | |
OS Oxford Science Enterprises | Oxford, United Kingdom | AcceleratorVenture capital | AIClimate | View fund | |
SS SOSV SF & NY (Fka IndieBio) | New York, United States | AcceleratorVenture capital | ClimateFood | View fund | |
V Venrock | New York, United States | Private equityVenture capital | AICommerce | View fund |
703 of 743 Genomics investment firms, A to Z
Grouped by first letter. Name and profile link only, the detailed rows are in the table above.ShowHide
A65
- A|impact
- AbbVie
- ABclonal
- Aberdeen Dynamics
- Abingworth
- Accelerace
- Accelerator Ventures
- AdAstral Funds
- Additional Ventures
- Adjuvant Capital
- Advanced Research Projects Agency for Health (ARPA-H)
- Advent Life Sciences
- Aescap
- Affinity Asset Advisors
- Agent Capital
- Agilent Technologies
- Agrizeronz
- Ahren Innovation Capital
- Aim-hi Accelerator Fund
- Airborn
- Alaska Permanent Fund
- Aldea Ventures
- Aliment Capital
- Alix Ventures
- Ally Bridge Group
- ALS Investment Fund
- ALSA Ventures
- Alta Life Sciences
- Altitude Life Science Ventures
- Altium Capital
- Alwyn Capital
- Alychlo
- Alzheimer's Foundation of America
- Amadeus Capital Partners
- Amboy Street Ventures
- Amino Collective
- aMoon Fund
- Ampersand Capital Partners
- Amplitude Ventures
- AMVS Capital
- Angra Partners
- Anthill Ivy ventures fund
- Apollo Health Ventures
- Applied Value
- Apposite Capital
- ARCH Venture Partners
- Arcus Investment
- Arix Bioscience
- Arrowhead Pharmaceuticals
- ARTIS Ventures
- ARUP Laboratories
- Asahi Kasei
- Astellas Pharma
- AstraZeneca
- Atain
- Ataria
- Atem Capital Fund
- August Global Partners
- Australia's Economic Accelerator (AEA)
- Australian Research Council (ARC)
- Avante Biocapital
- Averin Capital
- Avoro Capital
- Axon Ventures
- Azimuth Opportunity Fund
B53
- Bachmanity Capital
- Bay City Capital
- Bayer
- Baylor College of Medicine (Immunology, Allergy & Rheumatology)
- Beacon Capital
- BeiGene
- Ben Franklin Technology Partners of Southeastern Pennsylvania
- Berkeley Catalyst Fund
- Best
- Better Health Group
- Bio-Rad Laboratories
- Bio-Techne
- Bio4Dreams
- BioAdvance Capital
- Biocartis
- Bioeconomy Capital
- Biogen
- BioGenerator
- Biohub
- Bioluminescence Ventures
- bioMerieux
- BioNTech SE
- Biotechnology And Biological Sciences Research Council
- BioTrack Capital
- Bioventure Partners
- BioVentures Investors
- Bioverge Ventures
- Bloom Burton & Co.
- Blue Collective
- Blue Ocean Capital
- Bluebird Ventures
- Bohe Angel Fund
- Bold Capital
- Boldcap Ventures
- Boom Capital
- Boston Children's Hospital
- Bow Capital
- Boxer Capital Management
- BoxOne Ventures
- Boyuan Capital
- Bpd Partners
- Brace Pharma Capital
- Braidwell
- Brama One Ventures
- Break Off Capital
- Break Through Cancer
- Brightedge - American Cancer Society
- Bristol Myers Squibb
- BroadOak Capital Partners
- Broadview Ventures
- Bruker
- Bunker Hill Capital
- Buysse & Partners - Private Equity & Real Estate
C55
- Caligan Partners
- Calm/Storm
- Caltech
- Cambridge Enterprise
- Cambridge Innovation Capital
- Cambridge University Entrepreneurs
- Cancer Research Horizons
- Cancer Research Institute (CRI)
- Cancer Research UK (CRUK)
- Capital Dimensions
- Careventures
- Carma
- Carnegie Investment Bank
- Casdin Capital
- Cdib Capital
- CDMRP
- Celadon Partners
- Celgene
- Center Ventures
- Cerner
- CG Health Ventures
- Chan Zuckerberg Initiative
- Charleston Angel Partners
- Charme Capital Partners
- Chemical Angel Network
- Chiesi Farmaceutici
- Chuang House Capital 创瓴资本
- Chuang House Capital 创瓴资本
- CITIC Securities Company
- Civilization Ventures
- Claremont Creek Ventures
- Clarus Ventures
- Cmt Research Foundation
- CMTA
- Coalition For Epidemic Preparedness Innovations
- Codexis
- Codon Capital
- Commodore Capital
- Company Ventures
- Company Ventures
- Cormorant Asset Management
- Corundum Systems Biology
- Cosine
- Cota Capital
- CP Ventures
- Creacion Ventures
- Creathor Ventures
- Creator Fund
- Crossroads Health Ventures
- CS Capital Management
- Csem
- Cure EB
- Cure Ventures
- CureDuchenne Ventures
- Cystic Fibrosis Foundation
D26
- D3Jubilee Partners
- Danaher
- Danen Capital
- Dayli Partners
- DCVC Bio
- Deep Knowledge Group
- Deep Track Capital
- DeepTech & Climate Fonds (DTCF)
- Delphi Ventures
- Delta Dental of Oklahoma
- Deutsche Private Equity (DPE)
- Development Bank Of Wales
- Deyi Investment
- Diffusion Capital Partners
- Digital Garage
- Dingxin Capital
- Dnv Capital
- Domain Associates
- Dotmatics
- Double Point Ventures
- Dreavent
- Dria Ventures
- Driehaus Capital Management
- Droia Ventures
- Duchenne UK
- Dynamk Capital
E21
- E Squared Capital Management
- EAI Investments
- East Los Capital
- EcoR1 Capital
- eFund
- EGB Capital
- Elikon Venture
- Endeavour Vision
- Endpoint Ventures
- Endure Capital
- Enterprise Partners
- Entertech Istanbul Technopolis
- Eos
- Epidarex Capital
- EQT Group (EQT Life Sciences)
- Erasmus Mc
- Essex Bio-technology
- EUCLIDEAN CAPITAL
- Eventide Asset Management
- Evotec
- Exodus
F28
- F-Prime
- Faber
- Fairview Health Services
- Fall Line Capital
- Ferment.Co
- Ferring Pharmaceuticals
- Finchley Healthcare Ventures
- Finnish Business Angels Network (fiban)
- Fiscus Ventures
- Flagship Pioneering
- Fletcher Spaght
- Flywheel Ventures
- Fondazione Telethon
- Foresite Capital
- Forge Life Science Partners
- Forward Biolabs
- Fosun Pharma
- Foundation Fighting Blindness
- Foundation for Food & Agriculture Research
- Foundation Medicine
- Foundation Venture Capital Group
- Fournier-Majoie Foundation
- Fraser Finance
- Frazier Healthcare Partners
- Frazier's Funding Partners
- Freeflow Ventures
- Future Planet Capital
- FUTURX
G24
- Genentech
- Genesys Capital
- Genoa Ventures
- Genome British Columbia
- Genome Canada
- Genomic Health
- Ghisallo
- Gigafund
- Gilde Healthcare
- Gl Capital
- Global Bio Fund
- Global Health Impact Network & Funds
- Global Space Ventures
- Gobi Partners GBA
- Good Ai Capital
- Good Ventures
- Gopher Angels
- Gordonmd Global Investments
- Gore Range Capital
- Gotham Green Partners
- Granger Management
- Green Park & Golf Ventures
- GRIDX
H35
- Hadean Ventures
- HanAll Biopharma
- Hanwha Impact Partners
- Harmonix Fund
- Harrington Discovery Institute at University Hospitals
- Hatch Blue
- HBM Partners
- Health Catalyst Capital (HCC)
- HealthCare Ventures
- Healthier Capital
- HealthQuad
- Healthspan Capital
- HealthTech Capital
- HealthTech Investors
- Healthy Ventures
- Heartbeat Labs
- Heda Ventures
- Heights Capital Management
- Helicase Venture
- Hemex
- Hemi Ventures
- Heritage Group
- Highbury Group
- Hikma Ventures
- Hillspire
- HIP
- Hkstp - Hong Kong Science And Technology Parks
- HOF Capital
- Hologic (Formerly Gen-Probe)
- Howard Hughes Medical Institute (HHMI)
- Hua Nan Financial Holdings
- Human Longevity
- Humanwell
- Humboldt Fund
- Hydra Capital Group
I29
- iGlobe Partners
- IKJ Capital
- Illumina
- Illumina Ventures
- InCube Ventures
- Incyte
- India DeepTech
- Industrial Bank Of Korea
- Infinity Investment Partners
- Ing Belgium
- Inimiti Vc
- Innospark Ventures
- Innovation Saskatchewan
- Innovation UBC
- Innovatus Capital Partners
- Integra Holdings
- Intermountain Health
- InterSystems
- Inventures Investment Partners, impact Venture Capital
- Inveready
- Investing Women Angels
- Invoke Capital
- Ionis Pharmaceuticals
- Iowa Corn Growers Association
- IQVIA
- Ironfire Ventures
- Israel Japan Fund
- Istcapital
- Iungo Capital
J6
- JDRF T1D Fund
- JEITO
- Jennison Associates
- Jinqiu Capital
- JSL Health Capital
- Juniper
K15
- K2 HealthVentures
- K2 Venture Partners 险峰淇云
- Kaufman Financial Group
- KBI Biopharma
- KdT Ventures
- Kegonsa Capital Partners
- Kendall Capital Partners
- Kerna Ventures
- Kestrel Capital Group
- Kineticos Disruptor Fund
- Kiwoom Securities
- Klarman Family Foundation
- Kohli Ventures
- Korea Venture Investment
- Kos Biotechnology Partners
L29
- Lake Bleu Capital
- Lakewood & Company
- Laurion Capital Management
- LDV Partners
- LEAF Venture
- Leaps by Bayer
- Leerink Partners
- Legal & General
- Lexi Ventures
- Life Science Angels
- Life Sciences Greenhouse Of Pennsylvania
- Lifelink Ventures
- Lifespan Vision Ventures
- Lilly Ventures
- LionBird
- Lombard Odier Group
- LongeVC
- Longevity Vision
- LongevityTech.fund
- Longliv Ventures
- Longwood Fund
- Lotte Hb
- Loyal Valley Capital
- Ludwig Cancer Research
- Luma Group
- Luye Pharma
- Lyell Immunopharma
- LYFE Capital
- LYZZ CAPITAL
M37
- M Ventures
- Magnet Venture
- Maj Invest
- Marathon Venture Partners
- MarsBio
- Mason Wells
- Mass General Brigham
- Mass Medical Angels
- Massmutual
- Mastersfund™
- MBC BioLabs
- Med-fine Capital
- MEDA Angels
- Medical Excellence Capital
- MedImmune
- Merieux Equity Partners
- Meritz Securities
- Metaplanet
- Metis
- Michigan Angel Fund
- Michigan Capital Network
- Milltrust International
- Mirae Asset Capital Life Science
- MiraeAsset Financial Group
- Mission Bay Capital
- Mission BioCapital
- Mitre Ventures
- Moderna
- Modular Capital
- Mohr Davidow Ventures
- Monograph Capital
- Moore Venture Partners
- MP Healthcare Venture Management
- MPM BioImpact
- Muscular Dystrophy Association
- Myriad Genetics
- Mythos Group
N31
- Nanthealth
- Natera
- National Cancer Research Institute
- National Foundation For Cancer Research
- National Human Genome Research Institute
- Nationwide Children's Hospital
- Navigare Ventures
- ND Capital
- Nest.Bio
- Neurocrine Biosciences
- New Horizon Capital
- Newpath Management
- Nextech Invest
- Nference
- NFX
- NGN Capital
- Nice & Green Sa
- Nikon
- Nolan Capital
- Noon Ventures
- North Carolina Biotechnology Center
- Northpond Ventures
- Novalis Biotechnology Incubation
- Novalis Lifesciences
- NovaQuest Capital Management
- Novartis
- Novartis Institutes for Biomedical Research
- Novo Holdings
- Novo Nordisk
- Novo Nordisk Foundation
- Nsw Government
O15
- Octagon Capital Advisors
- Omega Funds
- Omron Ventures
- OMX Ventures
- Ontario Centre of Innovation
- Ontario Genomics
- OPKO Health
- Opus11 VC
- Orbit Malaysia
- Origin House
- Origin Pioneering
- OS Fund
- Otago Innovation
- OTV
- OUTSIZED VENTURES
P40
- P5 Health Ventures
- Pacific 8 Ventures
- Padda Health
- Page One Ventures
- Paladin Capital Group
- Paperboy Ventures
- Parent Project Muscular Dystrophy
- Parker Institute for Cancer Immunotherapy
- Parkwalk
- Parkwalk Advisors
- Patient Square Capital
- Patrick J. Mcgovern Foundation
- PBM Capital Group
- PenderFund Capital Management
- Perceptive Advisors
- PerkinElmer
- Petri
- Petrichor Asset Management
- PFM Health Sciences
- Pharmakon Advisors
- Pictet Group
- Pictet Group
- Pierre Fabre
- Pilani Innovation & Entrepreneurship Development Society
- Pilot Growth Equity
- Pivotal Life Sciences
- Platinum Asset Management
- Plexo Capital
- Point Field Partners
- Point72
- Prairie Crest Capital
- PrairieGold Venture Partners
- Precision BioSciences
- Premier Partners
- Premji Invest - US
- President International Development
- Principle Capital
- Procter & Gamble
- Proto Axiom
- PT. Lippo Karawaci, Tbk
Q9
- Qb3
- Qbic Fund | Venture Capital
- Qbn Capital
- QIAGEN
- Qianhai Fund of Funds
- Qiming Venture Partners USA
- quadraScope
- Quark Venture
- Quest Diagnostics
R22
- Rabo Ventures
- Raise Phiture philanthropical fund
- Ramen Ventures
- Recode Ventures
- Red Antler
- Red Cell Partners
- Redmile Group
- Refactor
- ReGen Ventures
- Regeneron
- Reimagined Capital
- Reimagined Ventures
- Remiges Ventures
- Research Corporation Technologies
- Rett Syndrome Research Trust
- Revelation Partners
- Ridgeback Capital
- Rising Tide VC
- Riverine Ventures
- Roche
- Rock Springs Capital
- RTI International
S57
- S2G Investments
- S32
- Sahsen Ventures
- Samsara BioCapital
- Sandpiper Ventures
- Sandwater
- Sanford Health
- Sangel
- Sano Ventures
- Santa Cruz Ventures
- Sapir Venture Partners
- Saras Capital
- Sarepta Therapeutics
- Schott
- Scientia Ventures
- SciFi VC
- Section 32
- Sectoral Asset Management
- Sekhmet Ventures
- Selvedge Venture
- Shakti
- Shinhan Capital
- Sigma Square Capital
- Simons Foundation
- Simya Vc
- Sirnaomics
- Sixth Element Capital
- Sixty Degree Capital
- Sky Ventures Group
- Skyline Capital
- Slingshot
- Sofina
- Soleus Capital Management
- Source Capital
- Sparkfood
- Sparkle Ventures
- Speedinvest
- Sphera Partners
- Spruce Capital Partners
- SR One Capital Management
- StartUp Health
- State Development & Investment
- State Farm
- Stic Ventures
- Strategic Partners
- Sucden Ventures
- Sun Mountain Capital
- Sunnybrook Research Institute
- Superstring Capital
- Surveyor Capital
- SV Health Investors' Dementia Discovery Fund (DDF)
- SVG Ventures
- Sxe Ventures
- SynBioVen
- Syncona Partners
- Synetro Group
- Sysmex America
T43
- Tachyon Ventures
- Taiho Ventures
- Tall Grass Ventures
- Tanarra Capital
- Tang Capital Management
- Target ALS
- Tavistock Life Sciences
- Teampact ventures
- TechAccel
- Techammer
- Technology Fund
- TECHU
- Techxas Ventures
- Tekla Capital Management
- Televenture Management
- Tellus Bioventures
- Tensor Ventures
- Terra Magnum Capital Partners
- Terra Vc
- The ALS Association
- The Children's Hospital of Philadelphia
- The Column Group
- The Francis Crick Institute
- The Helmsley Charitable Trust
- The Kaufmann Fund
- The Leukemia & Lymphoma Society’s Therapy Acceleration Program
- The Mark Foundation For Cancer Research
- The National Institutes of Health
- The Silverstein Foundation for Parkinson's with GBA
- Thin Air Labs
- Third Rock Ventures
- Third Security
- Three Leaf Ventures
- Tie Socal Angels
- Timberline Investments
- Time BioVentures
- TPG Biotech
- Trailhead Capital
- Trails Edge Capital Partners
- Tramway Venture Partners
- Tri Locum Partners
- TripleTree
- Tullis Health Investors
U7
- UCL Technology Fund
- UF Innovate | Ventures
- Ultragenyx
- Unfold.vc
- Uninvest
- UPMC
- Utopia
V15
- Vallis Capital Partners
- VC23 Capital
- Ventana Capital Management
- venture capitalist (3153808)
- Verily
- Verition Fund Management
- Versant Ventures
- Vertex Pharmaceuticals
- Vesper Biotechnologies
- Vesper Ventures SA
- Vida Ventures
- Vinci
- Virginia Catalyst
- Viva Bioinnovator
- Voima Ventures
W16
- WA4STEAM
- Washington Research Foundation
- We Venture Capital
- Wedo Venture Partners
- Wellcome Trust
- Wellington Shields
- Werfen
- Westlake BioPartners®
- WestRiver Group
- WI Harper Group
- Wilbe
- Wilson Sonsini Goodrich & Rosati
- Windham Capital Partners
- Wisconsin Investment Partners
- Wisemont Capital
- Witruth Capital
X5
- X Fund
- Xcellerant Ventures
- XEIA Venture Partners
- Xen Capital
- Xeraya Capital
Y9
- Yale Ventures
- Yandex
- YAYA Capital
- Yk Bioventures
- Yonsei University Health System
- Yorkville Partners
- Yuanta Investment Korea (유안타인베스트먼트)
- Yuhan
- Yuuwa Pty
Z4
- ZAKA VC
- Zapis Capital Group
- ZhenFund 真格基金
- Zodius Capital
#7
- 20/20 HealthCare Partners
- 3B Future Health Fund I & II
- 3i Partners
- 3SBio
- 4BIO Capital
- 4catalyzer
- 5AM Ventures
Frequently asked questions
How many Genomics investment firms are on RaiseHunt?
RaiseHunt lists 743 Genomics investment firms.
How many of them have a known portfolio?
738 of the 743 firms list at least one portfolio company, 6,287 known investments between them.
Who can I reach at these firms?
2,693 people working at them have a profile here, each with their role at the firm and whether an email address is on file.
Where are most Genomics investment firms based?
The largest concentrations are in San Francisco, New York and Boston.
What rounds do Genomics investment firms take part in?
Most list Seed and Series A among their stages.
How do I contact Genomics investment firms?
Every firm page shows whether an email address is on file, and the named contacts at that firm. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.
Is the list of Genomics investment firms free to browse?
Yes. The directory and every firm page are free to read. Matching your own startup against them requires an account.
Do Genomics funds only back Genomics companies?
No. A focus area is a signal of interest, not a restriction. Firms usually list several, and the useful question is whether the existing portfolio looks like the kind of company you are building.
How does a decision get made inside a firm?
Usually by a group rather than by the person you first spoke to. One partner sponsors the deal internally and takes it to the rest, which is why the process runs longer than an angel conversation and why a single enthusiastic meeting is not yet a commitment.
Does the location of a firm matter?
Less than it used to. Plenty of firms back companies outside their own city, and remote first meetings are normal. Being nearby helps with introductions and later conversations, but it is rarely the thing that decides an investment.
What if no firm on this list replies?
Usually the list was too short or too loosely matched, not that the company is unfundable. Widen it, tighten who you are writing to, and rewrite the first two lines of the message. Those lines decide whether anything below them gets read.
What is the difference between raising from a firm and raising from an angel?
An angel invests their own money and can decide alone, which usually makes the process shorter. A firm invests money it raised from other people, so it answers to those backers and normally runs a longer diligence process before it commits. Founders often raise from angels first and bring in a firm once there is more to show.
Who should I contact at Genomics investment firms?
A named partner or principal, not a general company address. Investment decisions sit with individual people, and a message that lands in a shared inbox usually stops there. Each fund page here lists the people we hold a profile for, with their role at the firm.
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal